Here's how much Moderna's CEO makes compared to competitors - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

Moderna announced very promising results for their long-awaited COVID-19 vaccine. Here's how much the company's CEO makes compared to competitors.

a week before Moderna's results, on November 9, with a similar 90% effectiveness rate.

In the table below, we compared Moderna against two different types of companies: mature, established pharma giants and smaller biotech startups similar in scale to Moderna. We also show compensation for three firms from Moderna's compensation peer group as reported in the company's — Incyte Corp., Bluebird Bio, and Nektar Therapeutics. A compensation peer group is a group of competitors that companies use to understand how its competition is paying executives to inform their own compensation decisions.

In the chart below, we show compensation for CEOs of Moderna and other pharmaceutical and biotech firms as disclosed in each firm's most recent proxy statement, split out by element. Hold your cursor over the labels at the top to highlight the different parts of the executives' compensation, and reference the bulleted list below for more information on each compensation element.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

'Impeachment of (Articles ) and Conviction for (Articles ) by U.S. House 2/3rds Vote Constituting Conviction Impeached With Judgement not Extending further than removal from Office upon Impeachment for and Conviction of Articles Same. '

good

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSİNESS

Business Business Latest News, Business Business Headlines